📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
4
RECENT COVERAGE · 3 ARTICLES
Viking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s Accelerate (NASDAQ:VKTX)
Viking Therapeutics (VKTX) faces a pivotal moment as oral GLP-1 candidates gain competitive intensity in a rapidly expanding therapeutic...
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?
The GLP-1 therapeutic market represents a structural growth opportunity that continues to expand beyond initial diabetes and obesity...
Viking Therapeutics (VKTX) Offers Potential With VK2735 Market Opportunity
VKTX received a Buy rating and $89 price target from Lake Street on May 28, implying substantial upside from prevailing levels. The...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice